Asio Capital LLC Reduces Stock Position in GE HealthCare Technologies Inc. $GEHC

Asio Capital LLC cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 13.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 50,908 shares of the company’s stock after selling 8,207 shares during the period. Asio Capital LLC’s holdings in GE HealthCare Technologies were worth $4,175,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. Empowered Funds LLC grew its holdings in shares of GE HealthCare Technologies by 6.1% in the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after purchasing an additional 1,665 shares during the period. Acadian Asset Management LLC purchased a new stake in shares of GE HealthCare Technologies in the first quarter valued at about $259,000. CW Advisors LLC grew its holdings in shares of GE HealthCare Technologies by 5.6% in the second quarter. CW Advisors LLC now owns 10,297 shares of the company’s stock valued at $763,000 after purchasing an additional 547 shares during the period. Cresset Asset Management LLC boosted its holdings in GE HealthCare Technologies by 12.5% in the 2nd quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock valued at $578,000 after purchasing an additional 865 shares during the last quarter. Finally, Jump Financial LLC boosted its holdings in GE HealthCare Technologies by 317.6% in the 2nd quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock valued at $2,084,000 after purchasing an additional 21,396 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 1.0%

Shares of NASDAQ:GEHC opened at $69.73 on Wednesday. The business has a 50-day moving average price of $76.48 and a 200 day moving average price of $77.98. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $31.82 billion, a price-to-earnings ratio of 15.29, a PEG ratio of 1.55 and a beta of 1.17. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the company posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.07%.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Piper Sandler lifted their price target on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. Barclays lifted their price target on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research report on Friday, February 6th. Citigroup reduced their price target on shares of GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 11th. Finally, Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $92.17.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.